今开:0.0 | 昨收:179.2 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:5.4645170765E10 |
Pharmayang2018-03-02 11:23
$Shire plc (SHPG)$ seeking alpha上说有收购rumor。这股票其实有点低估了。pipeline不错,债务稍微有点高,前几年收购了很多。总体不错,可以入手点,大家觉得如何?查看全文
淘沙见金2017-12-18 09:19
$Kala Pharmaceuticals, Inc.(KALA)$ 年底之前最后一个大的binary event - KPI-121针对干眼症的临床三期结果。之前的二期试验没有满足统计学的显著意义,这次三期要达到主要试验终点难度不小。KPI-121 针对的主要是急性干眼症,跟针对慢性干眼症Allergan$艾尔建医疗(AGN)$ 的 Restasis和 Shire $Sh...查看全文
淘沙见金2017-09-15 00:15
相信各位经常在电脑前面的雪友有时候会觉得眼睛很干,这个问题也一直困扰着作者。作者上个月去做眼睛检查的时候跟眼科医生说了一下这个问题,医生检查了一下发现作者确实有轻度的干眼症。主要原因是长时间面对着电脑手机屏幕,缺乏适时地眨眼或让眼睛休息,影响了双眼的泪液分泌,进而导致泪腺发炎...查看全文
$Shire plc (SHPG)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-15 AccNo: 0001193125-19-042285 Size: 43 KB 网页链接
$Shire plc (SHPG)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-02-07 AccNo: 0001193125-19-030862 Size: 11 KB 网页链接
$Shire plc (SHPG)$ 15-15D - Suspension of duty to report [Section 13 and 15(d)] Filed: 2019-02-07 AccNo: 0001193125-19-030877 Size: 15 KB 网页链接
$Shire plc (SHPG)$ 15-15D - Suspension of duty to report [Section 13 and 15(d)] Filed: 2019-02-07 AccNo: 0001193125-19-030901 Size: 15 KB 网页链接
$Shire plc (SHPG)$ EFFECT - Notice of Effectiveness Filed: 2019-02-06 AccNo: 9999999995-19-000100 Size: 1 KB 网页链接
$Shire plc (SHPG)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2019-02-04 AccNo: 0001193125-19-026825 Size: 26 KB 网页链接
$Shire plc (SHPG)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-04 AccNo: 0001193125-19-026837 Size: 21 KB 网页链接
$Shire plc (SHPG)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-04 AccNo: 0001193125-19-026847 Size: 21 KB 网页链接
$Shire plc (SHPG)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-04 AccNo: 0001193125-19-026859 Size: 21 KB 网页链接
$Shire plc (SHPG)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-04 AccNo: 0001193125-19-026869 Size: 21 KB 网页链接